An observational study in Spontaneous Bacterial Peritonitis, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-06-02.
Sponsored by Sohag University · Observational
Current reports have demonstrated that copeptin predicts disease progression and prognosis in cirrhotic patients, independent of liver-specific scoring systems. To the best of our knowledge, few studies have addressed the association between copeptin and sepsis in cirrhotic patients, however, they were performed on different types of infections. Therefore, we will conduct this study with a focus on it is possible role in patients with SBP.
185 studies on the registry are indexed under Peritonitis; 25 are open to participants now.
This study's enrollment of 89 is below the median of 127 across 59 observational studies indexed under Peritonitis.
Browse Peritonitis studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with liver cirrhosis and ascites
Exclusion Criteria:
Patients with heart failure, coronary insufficiency, advanced chronic respiratory disease, polyuria-polydipsia syndrome and hypotension or shock.
Cirrhotic ascitic patients not diagnosed with SBP
Diagnostic Test: Serum copeptin
Cirrhotic ascitic patients diagnosed with SBP
Diagnostic Test: Serum copeptin
Blood test
compare serum levels of copeptin in cirrhotic patients with and without SBP
compare serum levels of copeptin in cirrhotic patients with and without SBP
Time frame: 6 months
assess serum copeptin levels in different stages of cirrhosis and its relationship with kidney and circulatory function
assess serum copeptin levels in different stages of cirrhosis and its relationship with kidney and circulatory function
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University